| 000 | 01601 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517045105.0 | ||
| 264 | 0 | _c20160428 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1660-3397 | ||
| 024 | 7 |
_a10.3390/md13084949 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarms, Henrik | |
| 245 | 0 | 0 |
_aEpipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential. _h[electronic resource] |
| 260 |
_bMarine drugs _cAug 2015 |
||
| 300 |
_a4949-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAquatic Organisms _xmicrobiology |
| 650 | 0 | 4 |
_aAscomycota _xmetabolism |
| 650 | 0 | 4 |
_aBiological Products _xpharmacology |
| 650 | 0 | 4 |
_aCallyspongia _xmicrobiology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA _xdrug effects |
| 650 | 0 | 4 |
_aFungi _xmetabolism |
| 650 | 0 | 4 |
_aGliotoxin _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJurkat Cells |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPolyketides _xpharmacology |
| 650 | 0 | 4 |
_aPorifera _xmicrobiology |
| 700 | 1 | _aOrlikova, Barbora | |
| 700 | 1 | _aJi, Seungwon | |
| 700 | 1 | _aNesaei-Mosaferan, Damun | |
| 700 | 1 | _aKönig, Gabriele M | |
| 700 | 1 | _aDiederich, Marc | |
| 773 | 0 |
_tMarine drugs _gvol. 13 _gno. 8 _gp. 4949-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/md13084949 _zAvailable from publisher's website |
| 999 |
_c25155209 _d25155209 |
||